Sunil Healthcare Limited (NSE:SUNLOC)
India · Delayed Price · Currency is INR 70.20
+0.01 (0.01%)
At close: Nov 9, 2026
Sunil Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 694 | 635 | 672 | 632 | 585 | 730 | |
Market Cap Growth | -10.16% | -5.48% | 6.43% | 8.01% | -19.90% | 211.60% |
Enterprise Value | 1,228 | 1,209 | 1,259 | 1,088 | 868 | 1,086 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.24 | 15.86 | - | - | 8.75 | 11.37 |
PS Ratio | 0.83 | 0.72 | 0.81 | 0.70 | 0.53 | 0.61 |
PB Ratio | 1.00 | 0.91 | 1.00 | 0.93 | 1.04 | 1.46 |
P/TBV Ratio | 1.00 | 0.91 | 1.00 | 0.93 | 1.05 | 1.47 |
P/FCF Ratio | 3.74 | 3.42 | 32.19 | - | 17.90 | 5.42 |
P/OCF Ratio | 3.13 | 2.87 | 5.84 | - | 7.83 | 3.24 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.46 | 1.38 | 1.51 | 1.21 | 0.79 | 0.91 |
EV/EBITDA Ratio | 9.72 | 9.47 | 12.29 | 29.63 | 5.60 | 6.20 |
EV/EBIT Ratio | 19.88 | 19.11 | 32.22 | - | 9.46 | 9.45 |
EV/FCF Ratio | 6.62 | 6.51 | 60.26 | - | 26.58 | 8.06 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.80 | 0.80 | 1.02 | 0.97 | 0.66 | 0.69 |
Debt / EBITDA Ratio | 4.41 | 4.37 | 6.70 | 16.27 | 2.28 | 1.95 |
Debt / FCF Ratio | - | 3.01 | 32.87 | - | 11.26 | 2.57 |
Net Debt / Equity Ratio | 0.77 | 0.80 | 1.02 | 0.94 | 0.61 | 0.69 |
Net Debt / EBITDA Ratio | 4.23 | 4.37 | 6.70 | 17.43 | 2.21 | 1.96 |
Net Debt / FCF Ratio | - | 3.00 | 32.85 | -2.47 | 10.47 | 2.56 |
Asset Turnover | - | 0.54 | 0.52 | 0.65 | 0.96 | 1.03 |
Inventory Turnover | - | 1.88 | 2.31 | 3.35 | 4.07 | 4.22 |
Quick Ratio | - | 0.75 | 0.68 | 0.77 | 0.69 | 0.49 |
Current Ratio | - | 1.11 | 1.04 | 1.09 | 1.06 | 0.87 |
Return on Equity (ROE) | - | 5.86% | -2.09% | -2.88% | 12.61% | 13.71% |
Return on Assets (ROA) | - | 2.42% | 1.52% | -0.89% | 4.98% | 6.24% |
Return on Invested Capital (ROIC) | 4.98% | 4.85% | 2.92% | -1.80% | 7.41% | 9.09% |
Return on Capital Employed (ROCE) | - | 6.40% | 3.90% | -2.00% | 12.20% | 16.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.94% | 6.30% | -2.11% | -2.83% | 11.43% | 8.79% |
FCF Yield | 26.75% | 29.21% | 3.11% | -40.94% | 5.59% | 18.45% |